State of the art in radiolabeling of antibodies with common and uncommon radiometals for preclinical and clinical immuno-PET

M Chomet, GAMS van Dongen… - Bioconjugate chemistry, 2021 - ACS Publications
Inert and stable radiolabeling of monoclonal antibodies (mAb), antibody fragments, or
antibody mimetics with radiometals is a prerequisite for immuno-PET. While radiolabeling is …

ImmunoPET imaging of hematological malignancies: From preclinical promise to clinical reality

Y Dun, G Huang, J Liu, W Wei - Drug Discovery Today, 2022 - Elsevier
Immuno-positron emission tomography (immunoPET) imaging is a paradigm-shifting
imaging technique for whole-body and all-lesion tumor detection, based on the combined …

Diagnostic Positron Emission Tomography Imaging with Zirconium-89 Desferrioxamine B Squaramide: From Bench to Bedside

SE Rudd, A Noor, KA Morgan… - Accounts of Chemical …, 2024 - ACS Publications
Conspectus Molecular imaging with antibodies radiolabeled with positron-emitting
radionuclides combines the affinity and selectivity of antibodies with the sensitivity of …

[HTML][HTML] Evaluation of coumarin-tagged deferoxamine as a Zr (IV)-based PET/fluorescence dual imaging probe

GM Romano, V Zizi, G Salvatore, R Bani… - Journal of Inorganic …, 2023 - Elsevier
Desferoxamine (DFO) is currently the golden standard chelator for 89 Zr 4+, a promising
nuclide for positron emission tomography imaging (PET). The natural siderophore DFO had …

[HTML][HTML] Imaging of cell death in malignancy: Targeting pathways or phenotypes?

IH Shon, PJ Hogg - Nuclear Medicine and Biology, 2023 - Elsevier
Cell death is fundamental in health and disease and resisting cell death is a hallmark of
cancer. Treatment of malignancy aims to cause cancer cell death, however current clinical …

Heptadentate chelates for 89 Zr-radiolabelling of monoclonal antibodies

A Guillou, A Ouadi, JP Holland - Inorganic Chemistry Frontiers, 2022 - pubs.rsc.org
Herein, we report the synthesis of three new bifunctional heptadentate metal ion binding
chelates derived from desferrioxamine B (DFO) linked to a tripeptide unit that comprises of a …

Chelating Agents for Zirconium-89 in the Synthesis of Radiopharmaceuticals: Current State and Prospects of Development

VB Bubenshchikov, AA Larenkov - Russian Journal of Coordination …, 2022 - Springer
Zirconium is a highly demanded element widely used in various fields of science and
technology. There are 39 known zirconium isotopes, among which zirconium-89 (T 1/2 …

Preclinical evaluation of anti‐VEGFR2 monoclonal antibody ramucirumab labelled with zirconium‐89 for tumour imaging

Z Novy, J Janousek, P Barta, M Petrik… - Journal of Labelled …, 2021 - Wiley Online Library
The key factors participating in angiogenesis include vascular endothelial growth factor
(VEGF) and its receptors (VEGFRs), particularly VEGFR2. Angiogenesis suppression …

The RNA‐binding protein La/SSB associates with radiation‐induced DNA double‐strand breaks in lung cancer cell lines

AH Staudacher, Y Li, V Liapis, MP Brown - Cancer Reports, 2022 - Wiley Online Library
Background Platinum‐based chemotherapy and radiotherapy are standard treatments for
non‐small cell lung cancer, which is the commonest, most lethal cancer worldwide. As a …

Positron emission tomographic imaging of tumor cell death using Zirconium-89-labeled APOMAB® following cisplatin chemotherapy in lung and ovarian cancer …

V Liapis, W Tieu, NL Wittwer, T Gargett… - Molecular Imaging and …, 2021 - Springer
Purpose Early detection of tumor treatment responses represents an unmet clinical need
with no approved noninvasive methods. DAB4, or its chimeric derivative, chDAB4 …